Skip to main content
FDA panel rejects implanted GLP1-RA dosing device for T2D
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA panel rejects implanted GLP1-RA dosing device for T2D
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
Acute Kidney Injury
0
0.82
Renal Failure
0
0.73
Adherence
0
0.66
GLP-1 Receptor Agonist
0
0.99
Receptors
0
0.33
Toxicology
0
0.33
Prostate Cancer
0
0.27
Leukemia
0
0.19
Renal Cell Carcinoma
0
0.19
Allergy
0
0.16
Blood
0
0.16
Cancer
0
0.16
Colorado
0
0.16
Hospital
0
0.16
Injury
0
0.16
Kidney
0
0.16
Metabolism
0
0.16
Prostate
0
0.16
Wound Management
0
0.15
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Edit Tags